![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Akhondzadeh S. Tavakolian R. Davari-Ashtiani R. Arabgol F. Amini H.
Publisher: Elsevier
ISSN: 0278-5846
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.27, Iss.5, 2003-08, pp. : 841-845
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Bilici M. Yildirim F. Kandil S. Bekaroglu M. Yildirmis S. Deger O. Ulgen M. Yildiran A. Aksu H.
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder
Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. :